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SARS-CoV-2 Nasopharyngeal Swab Testing—
False-Negative Results From a Pervasive
Anatomical Misconception
A qualitative real-time polymerase chain reaction of
nasopharyngeal secretions is the criterion standard for
identifying respiratory viruses, including severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2).1
However, major concerns have been raised regarding
the rates of false-negative results in community testing
locations.2 In an early retrospective review of commu-
nity hospital testing in China, a sensitivity of only 71%
was reported.3 Although there are many sources of
false-negative results—including laboratory errors, pa-
tient misidentification, and inadequate collection of se-
cretions—improper technique resulting in swabs not
reaching the target site of the nasopharynx is a perva-
sive but modifiable error.
The trajectory from the nostril to the nasophar-
ynx is often presumed to be along the dorsum of the
nose, likely because of the visual appearance of the
external nose. In reality, the correct trajectory is along
the floor of the nose in the direction back toward the
ear (Figure). As otolaryngologists, we have long pro-
vided education to patients, nurses, and doctors
about this false anatomical presumption in treating
epistaxis. There is a tendency to place packing “up”
the nose where it may not only fail to reach the
intended location but also be uncomfortable for the
patient because the packing is wedged against the
middle turbinate.
The Centers for Disease Control and Prevention pro-
vides an accurate description of the technique to reach
the nasopharynx, stating1:
Insert minitip swab with a flexible shaft (wire or plas-
tic) through the nostril parallel to the palate (not
upwards) until resistance is encountered or the dis-
tance is equivalent to that from the ear to the nostril
of the patient, indicating contact with the nasophar-
ynx. Swab should reach depth equal to distance from
nostrils to outer opening of the ear. Gently rub and
roll the swab. Leave swab in place for several sec-
onds to absorb secretions. Slowly remove swab
while rotating it. Specimens can be collected from
both sides using the same swab, but it is not neces-
sary to collect specimens from both sides if the
minitip is saturated with fluid from the first collec-
tion. If a deviated septum or blockage create [sic] dif-
ficulty in obtaining the specimen from one nostril,
use the same swab to obtain the specimen from the
other nostril.
Although lower respiratory tract samples, such as
bronchoalveolar lavage and sputum specimens, dem-
onstrate higher viral loads in patients with SARS-
CoV-2 infection, nasopharyngeal swab (NPS) testing is
the best alternative to oropharyngeal swabs or exami-
nation of blood or stool.4 An NPS is widely used to
test for other respiratory viral infections and has sup-
planted nasopharyngeal aspiration for its accuracy
and convenience in this setting.5 However, poor tech-
nique in NPS testing may convert this test to a simple
nasal swab. The NPS is inherently uncomfortable even
with good technique, and a patient or the NPS opera-
tor may retract prematurely before the swab reaches
the correct location and is saturated with mucus. Lim-
ited attention has been paid to the effect of proper
technique on accuracy of results in NPS testing
even with regard to testing for influenza or jother
respiratory viruses. Of note, more tests are performed
in drive-through settings to provide convenience,
increase throughput, and adhere to social distancing
recommendations. Despite the rapid adoption of
this modality, a substantial review of its effect on
testing accuracy has not been done, and patient
and operator positioning may not be optimized
for proper NPS technique. Even more concerning
is the observation of facilities opting for patients to
self-administer swabs designed to reach the naso-
pharynx. Few laypersons could be expected to under-
stand the depth and trajectory required to perform
the test.
Three points need to be stressed to frontline
health care workers performing NPS: trajectory angle,
depth, and patient expectations. The swab should be
angled to follow the floor of the nose, and the depth
required to reach the nasopharynx is often surprising
to nonotolaryngologists: approximately 9 to 10 cm in
adults. For many swabs, this means that almost the
entire length is inserted into the nasal cavity, with only
a small portion left to be held outside the nose. Both
the patient and the operator should have proper
expectations for the procedure: the NPS is uncomfort-
able but should not cause severe pain. Such discom-
fort should indicate to the operator that an anatomical
obstruction, such as a deviated septum, is occluding
the pathway, and a modified trajectory or contralat-
eral approach should be attempted.
Given our subspecialty focus on nasal anatomy,
we have been involved in training personnel at our
respective institutions on the proper techniques for
NPS collection for SARS-CoV-2 testing, and we have
noticed pervasive misperception about the location of
the nasopharynx. Although many sites around the
world are likely providing proper training, we are con-
cerned that inadequate NPS collection may continue
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negative results in reverse transcriptase polymerase chain reac-
tion testing is a great concern because it underestimates the
prevalence of SARS-CoV-2 infection, gives a false sense of security
to patients and the health care workers caring for them, and limits
public health efforts in identifying and tracing the spread of the
virus. We hope highlighting that the nasopharynx is back, not up,
can help limit false-negative results in testing for SARS-CoV-2 and
other respiratory viruses.
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Figure. Diagram of Nasal Anatomy Showing the Correct () and
Incorrect (X) Trajectory for a Swab Directed Into the Nasopharynx (NP)
Skull base
NP
The NP is back, not up.
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